Literature DB >> 12665427

Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.

Zrinka Kovarik1, Zoran Radić, Harvey A Berman, Vera Simeon-Rudolf, Elsa Reiner, Palmer Taylor.   

Abstract

A series of eight double and triple mutants of mouse acetylcholinesterase (AChE; EC 3.1.1.7), with substitutions corresponding to residues found largely within the butyrylcholinesterase (BChE; EC 3.1.1.8) active-centre gorge, was analysed to compare steady-state kinetic constants for substrate turnover and inhibition parameters for enantiomeric methylphosphonate esters. The mutations combined substitutions in the acyl pocket (Phe(295)-->Leu and Phe(297)-->Ile) with the choline-binding site (Tyr(337)-->Ala and Phe(338)-->Ala) and with a side chain (Glu(202)--> Gln) N-terminal to the active-site serine, Ser(203). The mutations affected catalysis by increasing K (m) and decreasing k (cat), but these constants were typically affected by an order of magnitude or less, a relatively small change compared with the catalytic potential of AChE. To analyse the constraints on stereoselective phosphonylation, the mutant enzymes were reacted with a congeneric series of S (P)- and R (P)-methylphosphonates of known absolute stereochemistry. Where possible, the overall reaction rates were deconstructed into the primary constants for formation of the reversible complex and intrinsic phosphonylation. The multiple mutations greatly reduced the reaction rates of the more reactive S (P)-methylphosphonates, whereas the rates of reaction with the R (P)-methylphosphonates were markedly enhanced. With the phosphonates of larger steric bulk, the enhancement of rates for the R (P) enantiomers, coupled with the reduction of the S (P) enantiomers, was sufficient to invert markedly the enantiomeric preference. The sequence of mutations to enlarge the size of the AChE active-centre gorge, resembling in part the more spacious gorge of BChE, did not show an ordered conversion into BChE reactivity as anticipated for a rigid template. Rather, the individual aromatic residues may mutually interact to confer a distinctive stereospecificity pattern towards organophosphates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665427      PMCID: PMC1223469          DOI: 10.1042/BJ20021862

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Chiral reactions of acetylcholinesterase probed with enantiomeric methylphosphonothioates. Noncovalent determinants of enzyme chirality.

Authors:  H A Berman; K Leonard
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

2.  Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.

Authors:  L Wong; Z Radic; R J Brüggemann; N Hosea; H A Berman; P Taylor
Journal:  Biochemistry       Date:  2000-05-16       Impact factor: 3.162

3.  Thioflavin T is a fluorescent probe of the acetylcholinesterase peripheral site that reveals conformational interactions between the peripheral and acylation sites.

Authors:  G V De Ferrari; W D Mallender; N C Inestrosa; T L Rosenberry
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

4.  Ligand-induced conformational changes in acetylcholinesterase investigated with fluorescent phosphonates.

Authors:  D J Epstein; H A Berman; P Taylor
Journal:  Biochemistry       Date:  1979-10-16       Impact factor: 3.162

5.  Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs.

Authors:  J P Changeux
Journal:  Mol Pharmacol       Date:  1966-09       Impact factor: 4.436

6.  Use of procainamide gels in the purification of human and horse serum cholinesterases.

Authors:  J S Ralston; A R Main; B F Kilpatrick; A L Chasson
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

7.  Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.

Authors:  M Harel; J L Sussman; E Krejci; S Bon; P Chanal; J Massoulié; I Silman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  Synthesis and in vitro properties of a powerful quaternary methylphosphonate inhibitor of acetylcholinesterase. A new marker in blood-brain barrier research.

Authors:  D Levy; Y Ashani
Journal:  Biochem Pharmacol       Date:  1986-04-01       Impact factor: 5.858

9.  Inhibitors of different structure induce distinguishing conformations in the omega loop, Cys69-Cys96, of mouse acetylcholinesterase.

Authors:  Jianxin Shi; Zoran Radic'; Palmer Taylor
Journal:  J Biol Chem       Date:  2002-08-24       Impact factor: 5.157

10.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center.

Authors:  A Shafferman; B Velan; A Ordentlich; C Kronman; H Grosfeld; M Leitner; Y Flashner; S Cohen; D Barak; N Ariel
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  29 in total

1.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

Review 2.  Substrate tunnels in enzymes: structure-function relationships and computational methodology.

Authors:  Laura J Kingsley; Markus A Lill
Journal:  Proteins       Date:  2015-02-28

3.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

4.  Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging.

Authors:  Rory Cochran; Jaroslaw Kalisiak; Tuba Küçükkilinç; Zoran Radic; Edzna Garcia; Limin Zhang; Kwok-Yiu Ho; Gabriel Amitai; Zrinka Kovarik; Valery V Fokin; K Barry Sharpless; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

5.  Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.

Authors:  Rakesh K Sit; Zrinka Kovarik; Nikolina Maček Hrvat; Suzana Žunec; Carol Green; Valery V Fokin; K Barry Sharpless; Zoran Radić; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2018-09-06       Impact factor: 4.030

6.  Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.

Authors:  Nichole D Hein; Jeanne A Stuckey; Shirley R Rainier; John K Fink; Rudy J Richardson
Journal:  Toxicol Lett       Date:  2010-04-09       Impact factor: 4.372

7.  Investigating the structural influence of surface mutations on acetylcholinesterase inhibition by organophosphorus compounds and oxime reactivation.

Authors:  Tuba Küçükkilinç; Rory Cochran; Jaroslaw Kalisiak; Edzna Garcia; Anne Valle; Gabi Amitai; Zoran Radić; Palmer Taylor
Journal:  Chem Biol Interact       Date:  2010-04-09       Impact factor: 5.192

8.  HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.

Authors:  Nikolina Maček Hrvat; Suzana Žunec; Palmer Taylor; Zoran Radić; Zrinka Kovarik
Journal:  Chem Biol Interact       Date:  2016-04-12       Impact factor: 5.192

9.  Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin.

Authors:  Andrew C Hemmert; Tamara C Otto; Monika Wierdl; Carol C Edwards; Christopher D Fleming; Mary MacDonald; John R Cashman; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Mol Pharmacol       Date:  2010-01-05       Impact factor: 4.436

10.  Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.

Authors:  Nora H Barakat; Xueying Zheng; Cynthia B Gilley; Mary MacDonald; Karl Okolotowicz; John R Cashman; Shubham Vyas; Jeremy M Beck; Christopher M Hadad; Jun Zhang
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.